Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Medicine

Internal Medicine

Pediatrics

Hematology

Surgery

Show all topics

DOI

10.1016/s1470-2045(12)70600-9

License

CC-BY

Other Formats

PDF